CRO research roundup: Partnership, grant and milestone
Contract research organizations have seen a number of recent partnerships, grants and milestone payments. Here’s a quick round up of recent deals:
Archives for July 6, 2014
CDSCO issues raft of new trial regulations
Sponsors and CROs must ensure that clinical studies are properly designed and that investigators work on a maximum of three trials simultaneously under new guidelines issued by Indian regulators.
Kemwell's oral solid dose plant approved following joint European inspection
An oral solid dose manufacturing plant in Bangalore, India operated by CMO Kemwell Biopharma has passed a customer-prompted audit by European regulators and had its cGMP status renewed for the next three years.
Aarti Drugs considers formulations driven plant acqusition
Aarti Drugs has said it is considering buying an unnamed manufacturer in Himachal Pradesh, India to expand its drug formulations business
Merck Millipore says Indian lab can boost generics quality
Merck Millipore, the life sciences tools division of Merck KGaA, has launched a solid dose formulation lab in India, its first outside Europe.
Hospira finally completes Orchid plant acquisition
Hospira has paid Orchid Chemicals and Pharmaceuticals $218m (€160m) for an API plant in Aurangabad, India to increase its antibiotics production capacity and cut reliance on external suppliers.
European Commission outlines priorities for pharma sector in new report
In a sweeping report on the industry as a whole, the European Commission says that with an annual output of €220bn, and nearly 800,000 employees, the pharma industry is vital for the EU economy, though more needs to be done to meet its full potential.